having regard to the Council conclusions of 17 June 2016 on “Strengthening the balance in the pharmaceutical systems in the EU and its Member States”,
ob upoštevanju sklepov Sveta z dne 17. junija 2016 o krepitvi ravnovesja v farmacevtskih sistemih v EU in njenih državah članicah,